丙型肝炎的临床试验
总计5727个结果
-
Medical University of Graz撤销
-
Duke UniversityUniversity of North Carolina, Chapel Hill; Durham VA Medical Center完全的
-
Biocad完全的
-
Merck Sharp & Dohme LLC撤销
-
Bristol-Myers Squibb完全的
-
Janssen Pharmaceutica N.V., Belgium完全的
-
University of Missouri, Kansas CityReliant Pharmaceuticals; Saint Luke's Health System Foundation; Truman Medical Center撤销
-
Kaohsiung Medical University Chung-Ho Memorial...完全的
-
Nanogen Pharmaceutical Biotechnology Joint Stock...完全的
-
Debiopharm International SA终止
-
Bristol-Myers SquibbBasel Institute of Clinical Epidemiology (BICE)完全的
-
Bristol-Myers Squibb完全的
-
Vertex Pharmaceuticals Incorporated终止
-
Merck Sharp & Dohme LLC完全的
-
Mitsubishi Tanabe Pharma Corporation完全的
-
ANRS, Emerging Infectious DiseasesInstitut Pasteur; National Hepatology & Tropical Medicine Research Institute撤销
-
Vertex Pharmaceuticals Incorporated完全的
-
University of ManitobaRoche Pharma AG完全的
-
Dr. Nadia AbdelAaty AbdelKader终止
-
Gilead Sciences完全的
-
National Taiwan University HospitalNational Science Council, Taiwan; Department of Health, Executive Yuan, R.O.C. (Taiwan)未知
-
Weill Medical College of Cornell UniversityNational Institute of Allergy and Infectious Diseases (NIAID)终止
-
University of California, IrvineUniversity of California, Los Angeles; National Institute on Minority Health and Health Disparities...完全的
-
University of FloridaPatient-Centered Outcomes Research Institute; Merck Sharp & Dohme LLC; AbbVie完全的
-
Merck Sharp & Dohme LLC完全的
-
Changi General HospitalNational University Hospital, Singapore完全的
-
Merck Sharp & Dohme LLC完全的
-
Merck Sharp & Dohme LLC完全的
-
Janssen R&D Ireland完全的
-
Association HGE CHU Bordeaux SudUniversity Hospital, Bordeaux完全的
-
Bristol-Myers Squibb完全的
-
Bristol-Myers SquibbPharmasset完全的
-
Biocad完全的